ClinicalTrials.govpublic full text
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
glioblastoma, mgmt promotor status, overall survival, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980227
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.